Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Decreases By 45.1%

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 299,300 shares, a drop of 45.1% from the September 30th total of 544,800 shares. Based on an average daily volume of 1,700,000 shares, the days-to-cover ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Wednesday. They issued a “sell” rating for the company.

Aethlon Medical Price Performance

AEMD opened at $0.38 on Friday. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35. The stock’s 50 day moving average price is $0.41 and its 200 day moving average price is $0.59. The stock has a market cap of $5.21 million, a P/E ratio of -0.08 and a beta of 1.74.

Aethlon Medical (NASDAQ:AEMD) last released its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.44) by $0.10. During the same quarter last year, the firm posted ($1.30) EPS. Equities analysts anticipate that Aethlon Medical will post -1.1 EPS for the current year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.